Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| UTI Nifty Midcap 150 Index Fund | ANGEL ONE NIFTY TOTAL MARKET INDEX FUND | |
|---|---|---|
| Category | Index Funds (Equity) | Index Funds (Equity) |
| Plan | Direct | Direct |
| Fund house | UTI | Angel One |
| NAV | ₹10.9253 | ₹12.2790 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 2.0 years | 1.7 years |
| Expense ratio | 0.7% | 0.3% |
| Stars | Not rated | Not rated |
| Growth Score | — | — |
Returns
| UTI Nifty Midcap 150 Index Fund | ANGEL ONE NIFTY TOTAL MARKET INDEX FUND | |
|---|---|---|
| 1 month | +5.90% | +8.89% |
| 3 months | −2.68% | +2.78% |
| 6 months | +1.54% | +7.34% |
| YTD | +2.36% | +1.93% |
| 1 year | +1.71% | +1.35% |
| 3 years (CAGR) | — | — |
| 5 years (CAGR) | — | — |
| 10 years (CAGR) | — | — |
| Since launch | +3.53% | +11.49% |
Risk
| UTI Nifty Midcap 150 Index Fund | ANGEL ONE NIFTY TOTAL MARKET INDEX FUND | |
|---|---|---|
| Volatility | — | — |
| Downside volatility | — | — |
| Sharpe | — | — |
| Sortino | — | — |
| Calmar | — | — |
| Return / risk | — | — |
| Deepest fall | −18.92% | −14.81% |
| Days to recover | 102 | 226 |
| Below its high | −3.31% | +0.00% |
Against benchmark
| UTI Nifty Midcap 150 Index Fund | ANGEL ONE NIFTY TOTAL MARKET INDEX FUND | |
|---|---|---|
| Alpha | — | — |
| Beta | — | — |
| R² | — | — |
| Up capture | — | — |
| Down capture | — | — |
| Tracking error | — | — |
| Information ratio | — | — |
| Treynor | — | — |
Consistency
| UTI Nifty Midcap 150 Index Fund | ANGEL ONE NIFTY TOTAL MARKET INDEX FUND | |
|---|---|---|
| Best 1-year | +21.07% | +12.29% |
| Middle 1-year | +6.67% | +0.66% |
| Worst 1-year | −6.00% | −8.80% |
| 1-year periods with a loss | 7.9% | 38.6% |
| Middle 3-year | — | — |
| Positive months | — | — |
| Best day | +3.97% | +3.95% |
| Worst day | −3.95% | −3.38% |
| Worst 5% day | −2.01% | −1.39% |
| Positive days | 54.8% | 52.7% |
| NAVs a year | 247 | 246 |
SIP of ₹10,000 a month
| UTI Nifty Midcap 150 Index Fund | ANGEL ONE NIFTY TOTAL MARKET INDEX FUND | |
|---|---|---|
| 5-year XIRR | — | — |
| 5-year value | — | — |
| 3-year XIRR | — | — |
| 1-year XIRR | +5.65% | +9.51% |
Holdings overlap i
| UTI Nifty Midcap 150 Index Fund | ANGEL ONE NIFTY TOTAL MARKET INDEX FUND | |
|---|---|---|
| UTI Nifty Midcap 150 Index Fund | — | 19% |
| ANGEL ONE NIFTY TOTAL MARKET INDEX FUND | 19% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | UTI Nifty Midcap 150 Index Fund | ANGEL ONE NIFTY TOTAL MARKET INDEX FUND |
|---|---|---|
| Laurus Labs Limited | 2.40% | 0.47% |
| The Federal Bank Limited | 2.15% | 0.42% |
| Multi Commodity Exchange of India Limited | 2.08% | 0.41% |
| The Indian Hotels Company Limited | 1.82% | 0.36% |
| Coforge Limited | 1.82% | 0.36% |
| One 97 Communications Limited | 1.80% | 0.35% |
| Hero MotoCorp Limited | 1.72% | 0.34% |
| Persistent Systems Limited | 1.68% | 0.33% |
| Bharat Heavy Electricals Limited | 1.44% | 0.28% |
| IndusInd Bank Limited | 1.41% | 0.28% |
| AU Small Finance Bank Limited | 1.28% | 0.25% |
| Ge Vernova T&D India Limited | 1.27% | 0.25% |
| Lenskart Solutions Limited | 1.27% | 0.25% |
| Lupin Limited | 1.25% | 0.25% |
| Indus Towers Limited | 1.25% | 0.25% |
| Life Insurance Corporation Of India | 1.24% | 0.24% |
| FSN E-Commerce Ventures Limited | 1.22% | 0.24% |
| IDFC First Bank Limited | 1.22% | 0.24% |
| Bharat Forge Limited | 1.22% | 0.24% |
| Aurobindo Pharma Limited | 1.19% | 0.23% |
| Info Edge (India) Limited | 1.18% | 0.23% |
| Dixon Technologies (India) Limited | 1.17% | 0.23% |
| Marico Limited | 1.08% | 0.21% |
| Ashok Leyland Limited | 1.06% | 0.21% |
| Suzlon Energy Limited | 1.05% | 0.21% |
Sectors and company size
| UTI Nifty Midcap 150 Index Fund | ANGEL ONE NIFTY TOTAL MARKET INDEX FUND | |
|---|---|---|
| Large companies | 5.8% | 65.5% |
| Mid companies | 90.7% | 19.7% |
| Small companies | 2.5% | 14.7% |
| Top 10 holdings | 18.3% | 28.5% |
| Largest sector | Pharmaceuticals & Biotechnology 10% | Banks 19% |